Skip to main content
. 2018 Apr 3;90(14):e1204–e1211. doi: 10.1212/WNL.0000000000005254

Figure 3. Percentage change from baseline to end of treatment in plasma clobazam (CLB) and N-desmethylclobazam (N-CLB) concentrations.

Figure 3

(A) By treatment group. Note that 2 patients in the 5 mg/kg/d cannabidiol (CBD) group reduced CLB dose during treatment, but no reason was listed. (B) By stiripentol use in all patients on CBD. Error bars: SEM.